



Markets
/
Stocks
/
nasdaq-iclr
/

ICON PLC

ICLR

View Detailed Chart

144.960USD

-0.959-0.66%

Close 04/25, 16:00（ET）Quotes delayed by 15 min

11.71BMarket Cap

14.79P/E TTM



ICON PLC

144.960

-0.959-0.66%

Company

Intraday

30m

Today

-0.66%

5 Days

+4.05%

1 Month

-28.18%

6 Months

-34.25%

Year to Date

-30.88%

1 Year

-52.98%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 20 analysts

BUY

Current Rating

209.250

Target Price

44.35%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

556

Total

Median

Average

Company name

Ratings

Analysts

ICON PLC

ICLR

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Moderna Inc

MRNA

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(4)

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.300

Neutral

RSI(14)

38.170

Neutral

STOCH(KDJ)(9,3,3)

59.922

Buy

ATR(14)

9.597

Low Volatility

CCI(14)

-6.148

Neutral

Williams %R

51.645

Neutral

TRIX(12,20)

-1.294

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

140.476

Buy

MA10

142.451

Buy

MA20

155.386

Sell

MA50

183.008

Sell

MA100

199.884

Sell

MA200

256.380

Sell

News

More news coming soon, stay tuned...

Company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Company codeICLR

CompanyICON PLC

CEODr. Stephen (Steve) Cutler, Ph.D.

Websitehttps://www.iconplc.com/